CYCLOPHARM LIMITED — Capital/Financing Update 2021

Jan 31, 2021

1 February 2021

The Manager Company Announcements Office Australian Securities Exchange Limited 20 Bridge Street Sydney NSW 2000

==> picture [41 x 27] intentionally omitted <==

cyclo pharm

==> picture [41 x 27] intentionally omitted <==

cyclo medica techne gas ultra lute Cyclopharm Ltd ABN 74 116 931 250 Unit 4, 1 The Crescent Kingsgrove NSW 2208 Australia T 61 2 9541 0411 F 61 2 9543 0960 www.cyclopharm.com.au

CLEANSING NOTICE – SHARE PURCHASE PLAN

Cyclopharm Limited (the “Company”) gives this notice pursuant to ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547 (“Instrument”).

The Company will make offers to eligible shareholders to participate in a Share Purchase Plan (“SPP”). The SPP will provide eligible shareholders with an opportunity to purchase up to $30,000 of Cyclopharm ordinary shares (“Shares”) at an issue price of A$2.60 each.

In accordance with the Instrument, the Company advises that:

• 1 The Company will make offers to issue Shares under the SPP without disclosure to investors under Part 6D.2 of the Corporations Act 2001 (the “Act”);

• 2 As at the date of this notice, the Company has complied with:

  • (a) the provisions of Chapter 2M of the Act as they apply to the Company; and

  • (b) section 674 of the Act; and

• 3 As at the date of this notice, there is no information that is “excluded information” (in accordance with the requirements of subsections 708A(7) and (8) of the Act as if this notice were a notice under paragraph 708A(5)(e) of the Act).

This ASX announcement was approved and authorised for release by James McBrayer, Managing Director, CEO and Company Secretary.

For more information, please contact:

Mr James McBrayer Managing Director, CEO and Company Secretary Cyclopharm Limited T: +61 (02) 9541 0411

Page 1 of 1